Dilatair
Brand Name: Dilatair
Generic Name: Doxofylline
Active
Registration Number
DRP-6157-10
Dosage Form
Tablet
Issuance Date
March 31, 2025
Expiry Date
March 31, 2031
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength400 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 30's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Drug for Obstructive Airway Diseases
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
DoxofyllineActive
Monograph: Doxofylline